Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma
Clinical trial NCT01282476 · TERMINATED
Trial details
- NCT number
- NCT01282476
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2013-08-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.